This invention relates to the field of orthopedic implant devices, and more particularly, to an intramedullary fixation assembly used for fusion of the angled joints, bones and deformity correction, such as the hand and foot bones.
Orthopedic implant devices, such as intramedullary nails, plates, rods and screws are often used to repair or reconstruct bones and joints affected by trauma, degeneration, deformity and disease, such as Charcot arthropathy caused by diabetes in some patients, Hallux Valgus deformities, failed Keller Bunionectomies, Rheumatoid Arthritis, and severe deformities.
Moreover, infections and wound complications are a major concern in the aforementioned procedures. Wound closure is technically demanding for the surgeon, and devices that add surface prominence, such as plates or exposed screws, add to the difficulty by requiring greater tissue tension during incision reapproximation. This increases the risk of postoperative wound infections and dehiscence that may ultimately result in limb amputation.
Various implants have been utilized for surgical treatment of these bones and joints, including bone screws. Implants have also been utilized to treat severe deformities in the metatarsal and phalangeal bones, including multiple screws and plates. These multiple screws and plate implants have been commonly used in a first metatarsal-phalangeal fusion procedure to fuse the first metatarsal to the first phalangeal bone in hallux valgus deformities, failed keller bunionectomies, rheumatoid arthritis, and other types of severe deformities in the metatarsal and phalange bones. While these devices allow fixation and promote fusion, they do not deliver restoration of the arch in a Charcot foot, they are not effective in metatarsal-phalangeal (MTP) fusion procedures, nor do they deliver uniform compression for various predetermined angles of compression.
Particularly, screw implants in MTP procedures are ineffective in delivering sufficient compression to the bones in the foot, preventing screw head break out, or delivering effective bending resistance. Moreover, hard to control dorsiflexion and valgus angles as well skin irritation from proximity to the skin prevents these screw implants from being readily utilized for surgical treatment. Yet further, plate implants used with bone screws too have the same drawbacks as fixed varus and valgus angles, lack of direct compression across the MTP joint, and skin irritations from proximity to the skin reduce the effectiveness of these implants.
There is therefore a need for an intramedullary fixation assembly and method of use that overcomes some or all of the previously delineated drawbacks of prior fixation assemblies.
An object of the invention is to overcome the drawbacks of previous inventions.
Another object of the invention is to provide a novel and useful intramedullary fixation assembly that may be utilized to treat bones in a human body.
Another object of the invention is to provide a system for compressing bones using an intramedullary fixation assembly.
Another object of the invention is to fuse the bones in the human body through the use of an intraosseous intramedullary assembly.
Another object of the invention is to provide a fixed acute angle intramedullary fixation assembly for bone fixation.
Another object of the invention is to provide variable acute angles an intramedullary fixation assembly for bone fixation having variable acute angles of fixation.
Another object of the invention is to provide at least three point of compression on bone fragments through a variable angle intramedullary fixation assembly.
In a first non-limiting aspect of the invention, an intramedullary assembly for bone fusion is provided and includes a lag screw member and a tapered screw member. The lag screw member includes a first elongated body, where the first elongated body includes a first threaded portion at a first end and a bulbous portion at a second end. The tapered screw member is coupled to the lag screw member, and the tapered screw member includes a second elongated body, where the second elongated body includes a second threaded portion at a third end, and an opening at a fourth end.
In a second non-limiting aspect of the invention, a method for bone fusion includes eight steps. In step one, an intramedullary assembly is provided, where the intramedullary assembly includes a lag screw member having a first elongated body. The first elongated body includes a first threaded portion at a first end and a bulbous portion at a second end. The intramedullary assembly also includes a tapered screw member coupled to the lag screw member, where the tapered screw member includes a second elongated body having a second threaded portion at a third end, a tubular portion at a fourth end, and an opening at the fourth end. Step two includes making an incision in the foot. Step three includes drilling a first medullary canal in a first bone. Step four includes inserting the tapered screw member into the first medullary canal. Step five includes aligning the tapered screw member in the first medullary canal. Step six includes drilling a second medullary canal in the first bone. Step seven includes slideably coupling the lag screw member to the tapered screw member. Step seven includes inserting the lag screw member into the second medullary canal. Step eight includes applying compression to the lag screw member to lock the tapered screw member to the lag screw member, thereby fusing the first bone to the second bone.
A further understanding of the invention can be obtained by reference to a preferred embodiment set forth in the illustrations of the accompanying drawings. Although the illustrated embodiment is merely exemplary of systems and methods for carrying out the invention, both the organization and method of operation of the invention, in general, together with further objectives and advantages thereof, may be more easily understood by reference to the drawings and the following description. The drawings are not intended to limit the scope of this invention, which is set forth with particularity in the claims as appended or as subsequently amended, but merely to clarify and exemplify the invention.
For a more complete understanding of the invention, reference is now made to the following drawings in which:
The invention may be understood more readily by reference to the following detailed description of preferred embodiment of the invention. However, techniques, systems, and operating structures in accordance with the invention may be embodied in a wide variety of forms and modes, some of which may be quite different from those in the disclosed embodiment. Consequently, the specific structural and functional details disclosed herein are merely representative, yet in that regard, they are deemed to afford the best embodiment for purposes of disclosure and to provide a basis for the claims herein, which define the scope of the invention. It must be noted that, as used in the specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly indicates otherwise.
Referring now to
As shown in
Further, proximal screw member 130 has a first smooth exterior portion 206 extending from end 212 of bulbous portion 202. Portion 206 comprises an internal aperture 214 that longitudinally traverses portion 206 in direction 201. Portion 206 terminates into a second generally tubular portion 216. Portion 216 may comprise internal circular aperture 220 that longitudinally traverses inside portion 216. Internal circular aperture 220 is aligned with apertures 214 and 208 along axis 203 to form a continuous opening (i.e., a cannula) from bulbous portion 202 to end 204. The continuous opening or cannula is provided to interact with a guide wire (not shown) by receiving the guide wire within the continuous opening thereby positioning and locating the proximal member 130. In other non-limiting embodiments, the proximal member 130 may be provided without apertures 220 and 214 (i.e., the proximal member is solid).
Furthermore, tubular portion 216 has a plurality of circular threads, such as threads 218, which are circumferentially disposed on the external surface of portion 216 and, with threads 218 having an external diameter 224. Portion 216 may also be provided with a self-tapping leading edge 222 to provide portion 216 with the ability to remove bone material during insertion of proximal screw member 130 into bone. It should be appreciated that the length of the proximal member 130 may be selected of varying lengths to allow a surgeon to fuse different joints in a foot (not shown).
As shown in
Distal member 140 further comprises a generally smooth portion 310 coupled to end 302. Portion 310 has a generally hexagonal shaped aperture 312, which opens into aperture 316 and which longitudinally traverses through portion 310 in direction 301. In other non-limiting embodiments, a star-shaped aperture, a square-shaped aperture, or any other shaped aperture may be utilized. Circular aperture 316 has a diameter 314 that is slightly larger than external diameter 224 of portion 216 and 206 of proximal screw member 130, with portions 216 and 206 being slidably received within aperture 316 of portion 310. Aperture 316 has a diameter that is smaller than diameter 226 of bulbous portion 202.
Portion 310 of distal member 140 terminates into a second generally cylindrical portion 318 which has a plurality of threads 324, which are circumferentially disposed on the external surface of portion 318. Portion 318 has an internal circular aperture 327 which is longitudinally coextensive with portion 318 in direction 301. Circular aperture 327 aligns with aperture 312 to form a continuous opening from end 302 to end 304.
As shown in
Planar portion 408 is coupled to planar portion 422, with portion 422 having a width slightly smaller than width of portion 408. Portion 422 terminates into a generally “U-shaped” portion 424 with portion 424 being orthogonal to portion 422. Further, portion 424 has a plurality of substantially similar sides 426 and 428 which are provided to be slidably coupled to grooves 326 and 328 of distal member 140.
In operation, sides 426 and 428 of instrument 120 are received in respective grooves 326 and 328 of distal member 140, of
In operation, and as best shown in
As shown in
Next, in step 708, the instrument 120 is coupled to the distal member 140 by coupling sides 426 and 428 of instrument 120 to respective grooves 326 and 328. In step 710, initial positioning of the proximal member 130 is assessed with the use of a guide wire through portion 412 (i.e., aiming device). Next, in step 712, a countersink drill is inserted through portion 412 and the proximal cortex is penetrated. In this step, a cannulated drill or guide wire is used to pre-drill the hole through the joints selected for fusion. In step 714, the proximal screw member 130 is inserted over the guide wire and into the distal member 140. Particularly, the proximal member 130 is inserted through tubular portion 412 (i.e., aiming device), causing proximal member 130 to travel through internal longitudinal aperture 420, into distal member 140 and further into bones 504, 506 and 508 until rigid connection with the tapered aperture 316 is made, thereby compressing the joint. In one non-limiting embodiment, a locking element (not shown) such as a plate or a washer is coupled to end 302 of the intramedullary fixation assembly 110 to further secure proximal threaded member 130 to distal member 140. Next, in step 716 the instrument 120 is removed and the dorsal Lis Franc (i.e., mid-foot) incision is closed. The method ends in step 718.
It should be appreciated that a plurality of intramedullary fixation assemblies, such as intramedullary fixation assembly 110, may be inserted into any of the bones of a foot 500 such as, but not limited to the metatarsal, cuneiform, calcaneus, cuboid, talus and navicular bones, in order to restore the natural anatomical shape of the arch of the foot 500. Thus, the fixation system 100, in one non-limiting embodiment, is utilized to couple the intramedullary fixation assembly 110 to the foot 500, which causes the metatarsal 504, medial cuneiform 504, navicular 506 and talus 508 bones to be aligned to the proper anatomical shape of an arch when assembled within foot 500. It should be appreciated that the intramedullary fixation assembly 110 is delivered through a dorsal midfoot incision, thereby reducing the disruption to the plantar tissues and/or the metatarsal heads while at the same time minimizing the tension on the skin. This allows for improved wound closure, reduced operating room time, reduction in the number of incisions required and reduction in the total length of incisions. It should also be appreciated that in other non-limiting embodiments, the intramedullary assembly 110 may be utilized with graft material (i.e., autograft, allograft or other biologic agent).
In an alternate embodiment, as shown in
Also as shown in
As shown in
Further, lag screw member 815 has a first smooth exterior portion 1005 that has a uniform diameter 1025 from first end 1040 to second end 1045. Portion 1005 includes an internal aperture 1050 aligned along axis 1002 that traverses the longitudinal length of portion 1005 in direction 1000. Further, portion 1005 terminates into a threaded portion 1015. Threaded portion 1015 includes an internal aperture 1055 aligned along axis 1002 that longitudinally traverses threaded portion 1015. Internal aperture 1055 being aligned on the same axis 1002 as apertures 1035 and 1055 cooperatively form a continuous opening (i.e., a cannula) from end 1030 of bulbous portion 1010 to end 1060 of threaded portion 1015. The continuous opening or cannula is provided to interact with a guide wire (not shown) by receiving the guide wire within the continuous opening to help guide and position the lag screw member 815 during insertion of the lag screw member 815. In other non-limiting embodiments, the lag screw member 815 may be provided without apertures 1050 and 1055 (i.e., the lag screw member 815 is solid).
Furthermore, threaded portion 1015 has a plurality of circular threads, such as threads 1065, which are circumferentially disposed on the external surface of threaded portion 1015. Threaded portion 1015 has a diameter 1020 that is substantially the same as diameter 1025 of portion 1005. Threaded portion 1015 may also be provided with a self-tapping leading edge 1070 to provide portion 1015 with the ability to remove bone material during insertion of lag screw member 815 into bone. It should be appreciated that the length of the lag screw member 815 may be selected of varying lengths to allow a surgeon to fuse different joints in the human body. It should be appreciated that the lag screw member 815 may be positioned at one angle inside the tapered screw member 810. Also, lag screw member 815 may be coated with an osteoconductive material, such as, for example, plasma spray or other similar types of porous materials that is capable of supporting or encouraging bone ingrowth into this material.
As shown in
Further, tapered portion 1110 is generally tubular in shape and tapers from end 1120 to end 1125 (i.e. end 1120 has a diameter 1127 that decreases slightly in diameter from end 1120 in direction 1100). Further, first end 1120 has a tapered aperture 1130, which traverses tapered portion 1110 along axis 1102, which causes tapered aperture 1130 to emanate from surface 1135. Axis 1102 is offset from longitudinal axis 1104 at an angle 1140. Moreover, tapered portion 1110 has a generally hexagonal-shaped aperture contained within portion 1110, which is aligned along axis 1104 and is provided to receive an instrument (not shown) for applying torque to tapered screw member 810. In other non-limiting embodiments, a star-shaped aperture, a square-shaped aperture, or any other shaped aperture may be utilized without departing from the scope of the invention. With tapered aperture 1130 being aligned along axis 1102, tapered aperture 1130 forms a fixed angle 1140 with longitudinal axis 1145. Fixed angle 1140 determines the angle for fixation of tapered screw member 810 with respect to lag screw member 815 (shown in
Further, tapered screw member 810 has a smooth exterior portion 1105 that has a uniform diameter 1145 from end 1125 to end 1150. Tapered screw member 810 is generally solid, however, in other non-limiting embodiments, screw member 810 may be cannulated. Further, portion 1105 terminates into a threaded portion 1115. Threaded portion 1115 is generally solid and includes a plurality of circular threads, such as threads 1155, which are circumferentially disposed on the external surface of threaded portion 1115. Threaded portion 1115 has a diameter 1160 that is substantially the same as diameter 1145 of portion 1105. Threaded portion 1115 may also be provided with a self-tapping leading edge 1165 to provide portion 1115 with the ability to remove bone material during insertion of tapered screw member 810 into bone. It should be appreciated that the length of the tapered screw member 810 may be selected of varying lengths to allow a surgeon to fuse different joints in the human body. It should be appreciated that tapered screw member 810 may be coated with an osteoconductive material, such as, for example, plasma spray or other similar types of porous materials that is capable of supporting or encouraging bone ingrowth into this material.
As shown in
Next, in step 1220, the final position of the tapered screw member 810 is aligned so that the coupling of the lag screw member 815 forms a predetermined angle with the tapered screw member 810. In step 1225, align a guide through tapered aperture 1130 at surface 1135 and pre-drill a hole through the joint substantially along axis 1102. Next, in step 1230, insert a K-wire (not shown) into the pre-drilled hole and into the tapered screw member 810 so that the K-wire makes an acute angle with the tapered screw member 810. Next, in step 1235, the lag screw member 815 is rotated and inserted over the K-wire and into the calcaneus bone 820 so that the K-wire guides the lag screw member 815. The K-wire, in assisting the lag screw member 815, penetrates end 1060 and emanates from end 1030. In some non-limiting embodiments, the lag member 815 may be inserted by impaction, by press fit, or substantially any other similar strategy or technique. Next, in step 1240, the K-wire is removed and the incision is closed. The method ends in step 1245.
In an alternate embodiment, as shown in
In another alternate embodiment, as shown in
As shown in
Further, lag screw member 1415 has a first smooth exterior portion 1505 of a uniform diameter 1525 from first end 1540 to second end 1545. Portion 1505 includes an internal aperture 1550 aligned along axis 1502 that traverses the longitudinal length of portion 1505 along direction 1504. Further, portion 1505 terminates into the threaded portion 1515. Threaded portion 1515 also includes an internal aperture 1555 aligned along axis 1502 that longitudinally traverses threaded portion 1515. Internal aperture 1555 being aligned along the same axis 1502 as apertures 1535 and 1550 cooperatively form a continuous opening (i.e., a cannula) from bulbous portion 1510 to end 1560 of threaded portion 1515. The continuous opening or cannula is provided to interact with a guide wire (not shown) by receiving the guide wire within the continuous opening to help guide and position the lag screw member 1415 during insertion into bone. In other non-limiting embodiments, the lag screw member 1415 may be provided without apertures 1550 and 1555 (i.e., the lag screw member 1415 is non-cannulated or solid).
Furthermore, threaded portion 1515 has a plurality of circular threads, such as threads 1565, which are circumferentially disposed on the external surface of threaded portion 1515. Threaded portion 1515 has a diameter 1520 that is substantially the same as diameter 1525 of portion 1505. Threaded portion 1515 may also be provided with a self-tapping leading edge (not shown) to provide portion 1515 with the ability to remove bone material during insertion of lag screw member 1415 into bone. It should be appreciated that the length of the lag screw member 1415 may be selected of varying lengths to allow a surgeon to fuse different joints in the human body. Also, lag screw member 1415 may be coated with an osteoconductive material, such as, for example, plasma spray or other similar types of porous materials that is capable of supporting or encouraging bone ingrowth into this material.
As shown in
Further, portion 1610 is generally tubular in shape having a uniform diameter, which is slightly larger than diameter of aperture 1630 causing portion 1610 to abut the interior surface of portion 1610 at aperture 1630. However, in other non-limiting embodiments, portion 1610 may be tapered going from a larger diameter to a smaller diameter as we traverse portion 1610 along direction of axis 1600. Further, portion 1610 has a plurality of apertures 1620 and 1630 of dissimilar diameters. Aperture 1630 is a through aperture and is tapered along axis 1602, causing aperture 1630 to emanate from surface 1635. On the other hand, aperture 1620 is longitudinally disposed along axis 1604 and has a generally hexagonal shaped aperture, although in other non-limiting embodiments, a star-shaped aperture, a square-shaped aperture, or any other shapes aperture may be utilized. Aperture 1630 is offset from axis 1604 at an angle 1640. Angle 1640 determines the angle for rotation of lag screw member 1415 when bulbous portion 1510 (shown in
Further, polyaxial screw member 1410 has a smooth exterior portion 1605 having a uniform diameter from end 1625 to end 1650. The diameter of exterior portion 1605 is smaller than the diameter of aperture 1630. Polyaxial screw member 1410 is generally solid, however, in other non-limiting embodiments, polyaxial screw member 1410 may be cannulated. Further, portion 1605 terminates into a threaded portion 1615. Threaded portion 1615 is generally solid and includes a plurality of circular threads, such as threads 1655, circumferentially disposed on the external surface of threaded portion 1615. Threaded portion 1615 has a uniform diameter that is slightly larger than the diameter of portion 1605. However, in other non-limiting embodiments, the respective diameters of portions 1605 and 1615 may be substantially the same. Threaded portion 1615 may also be provided with a self-tapping leading edge (not shown) to provide portion 1615 with the ability to remove bone material during insertion of polyaxial screw member 1410 into bone. It should be appreciated that the length of the polyaxial screw member 1410 may be selected of varying lengths to allow a surgeon to fuse different joints in the human body. It should be appreciated that polyaxial screw member 1410 may be coated with an osteoconductive material, such as, for example, plasma spray or other similar types of porous materials that is capable of supporting or encouraging bone ingrowth into this material.
In another alternate embodiment, as shown in
In another alternate embodiment, as shown in
As shown, tapered screw member 1815 is generally cylindrical in shape and has a smooth exterior portion 1820 that extends longitudinally along axis 1806 from end 1825 to a threaded portion 1830. Further, end 1825 has a tapered aperture 1835, which is aligned on axis 1802 and forms a fixed angle 1808 with axis 1806. Fixed angle 1808 determines the angle for fixation of tapered screw member 1810 with respect to lag screw member 1805. Also, tapered screw member 1815 has a second tapered aperture 1840, aligned along axis 1804 and forms a fixed angle 1812 with axis 1804. The fixed angle 1812 determines the angle for fixation of lag screw member 1810 with tapered screw member 1815. It should be appreciated that fixed angles 1808 and 1812 may be any angle less than 90 degrees to allow a surgeon the flexibility of determining the angle for internal fixation of bones in the human body. It should also be appreciated that tapered screw member 1815 creates a locked interference fit with each of the lag screw members 1805 and 1810.
Further, tapered screw member 1815 has a smooth exterior portion 1820 having a uniform diameter from end 1825 to threaded portion 1830. Tapered screw member 1815 is generally solid, however, in other non-limiting embodiments, screw member 1815 may be cannulated. Further, threaded portion 1830 is generally solid and includes a plurality of circular threads circumferentially disposed on the external surface of threaded portion 1830. Threaded portion 1830 may also be provided with a self-tapping leading edge to provide portion 1830 with the ability to remove bone material during insertion of tapered screw member 1815 into bone. It should be appreciated that the length of the tapered screw member 1815 may be selected of varying lengths to allow a surgeon to fuse different joints in the human body. It should be appreciated that tapered screw member 1815 may be coated with an osteoconductive material, such as, for example, plasma spray or other similar types of porous materials that is capable of supporting or encouraging bone ingrowth into this material.
Also as shown in
In an alternate embodiment, as shown in
It should be appreciated that any number of intramedullary fixation assemblies, such as intramedullary fixation assembly 800, may be inserted into the joints, for example, of the human foot in order to provide for compression of the bones of the foot. It should also be appreciated that the intramedullary fixation assembly 800 is delivered through an incision, thereby reducing the disruption to the plantar tissues while at the same time minimizing the tension on the skin. This allows for improved wound closure, reduced operating room time, reduction in the number of incisions required and reduction in the total length of incisions. It should also be appreciated that the intramedullary fixation assembly 800 may also be utilized to restore any of the other bones in the human body. It should also be appreciated that in other non-limiting embodiments, the intramedullary assembly 800 may be utilized with graft material (i.e., autograft, allograft or other biologic agent).
It should also be understood that this invention is not limited to the disclosed features and other similar method and system may be utilized without departing from the spirit and the scope of the invention.
While the invention has been described with reference to the preferred embodiment and alternative embodiments, which embodiments have been set forth in considerable detail for the purposes of making a complete disclosure of the invention, such embodiments are merely exemplary and are not intended to be limiting or represent an exhaustive enumeration of all aspects of the invention. The scope of the invention, therefore, shall be defined solely by the following claims. Further, it will be apparent to those of skill in the art that numerous changes may be made in such details without departing from the spirit and the principles of the invention. It should be appreciated that the invention is capable of being embodied in other forms without departing from its essential characteristics.
This application is a continuation of U.S. patent application Ser. No. 17/002,005, filed on Aug. 25, 2020, which is a continuation of U.S. patent application Ser. No. 15/884,048, filed on Jan. 30, 2018, which is a continuation of U.S. patent application Ser. No. 15/181,435, filed on Jun. 14, 2016, which is a continuation of U.S. patent application Ser. No. 14/599,671, filed on Jan. 19, 2015, which is a divisional of U.S. patent application Ser. No. 12/658,680, filed Feb. 11, 2010, which is a continuation-in-part application of U.S. patent application Ser. No. 12/456,808, filed Jun. 23, 2009, which claims the benefit of Provisional Patent Application No. 61/132,932, filed Jun. 24, 2008. The entire contents of the entire chain of applications are herein incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
2580821 | Nicola | Jan 1952 | A |
2398220 | Gelpcke | Apr 1956 | A |
3018986 | Behrle | Feb 1962 | A |
3411398 | Blakeley et al. | Nov 1968 | A |
3474537 | Christensen | Oct 1969 | A |
3924276 | Eaton | Dec 1975 | A |
4152533 | Gazda | May 1979 | A |
4381770 | Neufield | May 1983 | A |
4465065 | Gotfried et al. | Aug 1984 | A |
4622959 | Marcus | Nov 1986 | A |
4760843 | Fischer et al. | Aug 1988 | A |
4795294 | Takada et al. | Jan 1989 | A |
4854797 | Gourd | Aug 1989 | A |
4930963 | Rockenfeller et al. | Jun 1990 | A |
4940467 | Tronzo | Jul 1990 | A |
4947502 | Engelhardt | Aug 1990 | A |
4987714 | Lemke | Jan 1991 | A |
5084050 | Draenert | Jan 1992 | A |
5112333 | Fixel | May 1992 | A |
5163940 | Bourque | Nov 1992 | A |
5209753 | Biedermann | May 1993 | A |
5350380 | Goble et al. | Sep 1994 | A |
5403321 | DiMarco | Apr 1995 | A |
5454267 | Moreau et al. | Oct 1995 | A |
5456267 | Stark | Oct 1995 | A |
5478341 | Cook et al. | Dec 1995 | A |
5501557 | Wakai | Mar 1996 | A |
5505731 | Tornier | Apr 1996 | A |
5531748 | de la Caffiniere | Jul 1996 | A |
5540694 | DeCarlo, Jr. et al. | Jul 1996 | A |
5613971 | Lower et al. | Mar 1997 | A |
5620449 | Faccioli et al. | Apr 1997 | A |
5702470 | Menon | Dec 1997 | A |
5718705 | Sammarco | Feb 1998 | A |
5718706 | Roger | Feb 1998 | A |
5766221 | Benderev et al. | Jun 1998 | A |
5779704 | Kim | Jul 1998 | A |
5779705 | Matthews | Jul 1998 | A |
5857816 | Assmundson | Jan 1999 | A |
5865559 | Yang | Feb 1999 | A |
5888203 | Goldberg | Mar 1999 | A |
5891150 | Chan | Apr 1999 | A |
5968050 | Torrie | Oct 1999 | A |
5984681 | Huang | Nov 1999 | A |
5997541 | Schenk | Dec 1999 | A |
D420132 | Bucholz et al. | Feb 2000 | S |
6019761 | Gustillo | Feb 2000 | A |
6030162 | Huebner | Feb 2000 | A |
6048343 | Mathis et al. | Apr 2000 | A |
6106528 | Durham et al. | Aug 2000 | A |
6120511 | Chan | Sep 2000 | A |
6123709 | Jones | Sep 2000 | A |
6123711 | Winters | Sep 2000 | A |
6168595 | Durham et al. | Jan 2001 | B1 |
6168597 | Biedermann et al. | Jan 2001 | B1 |
6174119 | Off | Jan 2001 | B1 |
6214007 | Anderson | Apr 2001 | B1 |
6214012 | Karpman et al. | Apr 2001 | B1 |
6221074 | Cole et al. | Apr 2001 | B1 |
6235031 | Hodgeman et al. | May 2001 | B1 |
6247883 | Monserratt | Jun 2001 | B1 |
6254605 | Howell | Jul 2001 | B1 |
6254606 | Carney et al. | Jul 2001 | B1 |
6261290 | Friedl | Jul 2001 | B1 |
6270499 | Leu et al. | Aug 2001 | B1 |
6280442 | Barker et al. | Aug 2001 | B1 |
6287313 | Sasso | Sep 2001 | B1 |
6379354 | Rogozinski | Apr 2002 | B1 |
6379362 | Birk et al. | Apr 2002 | B1 |
6402753 | Cole et al. | Jun 2002 | B1 |
6402757 | Moore et al. | Jun 2002 | B1 |
6423064 | Kuger | Jul 2002 | B1 |
6443954 | Bramlet et al. | Sep 2002 | B1 |
6517541 | Sesic | Feb 2003 | B1 |
6527775 | Warburton | Mar 2003 | B1 |
6562046 | Sasso | May 2003 | B2 |
6569165 | Wahl et al. | May 2003 | B2 |
6579293 | Chandran | Jun 2003 | B1 |
6589245 | Weiler et al. | Jul 2003 | B1 |
6596008 | Kambin | Jul 2003 | B1 |
6626916 | Yeung et al. | Sep 2003 | B1 |
6629976 | Gnos et al. | Oct 2003 | B1 |
6648889 | Bramlet et al. | Nov 2003 | B2 |
6669700 | Farris et al. | Dec 2003 | B1 |
6679888 | Green et al. | Jan 2004 | B2 |
6692496 | Wardlaw | Feb 2004 | B1 |
6692503 | Foley et al. | Feb 2004 | B2 |
6709436 | Hover et al. | Mar 2004 | B1 |
6712849 | Re et al. | Mar 2004 | B2 |
6778861 | Leibrecht et al. | Aug 2004 | B1 |
6793659 | Putnam | Sep 2004 | B2 |
6808527 | Lower et al. | Oct 2004 | B2 |
6849093 | Michelson | Feb 2005 | B2 |
6875216 | Wolf | Apr 2005 | B2 |
6951538 | Ritland | Oct 2005 | B2 |
6951561 | Warren et al. | Oct 2005 | B2 |
6981974 | Berger | Jan 2006 | B2 |
7018380 | Cole | Mar 2006 | B2 |
7037309 | Weil et al. | May 2006 | B2 |
7041104 | Cole et al. | May 2006 | B1 |
7063724 | Re et al. | Jun 2006 | B2 |
7074221 | Michelson | Jul 2006 | B2 |
7160302 | Warburton | Jan 2007 | B2 |
7175632 | Singhatat et al. | Feb 2007 | B2 |
7229448 | Goble et al. | Jun 2007 | B2 |
7232442 | Sohngen et al. | Jun 2007 | B2 |
7247156 | Ekholm et al. | Jul 2007 | B2 |
7267678 | Medoff | Sep 2007 | B2 |
7326248 | Michelson | Feb 2008 | B2 |
7331962 | Branemark | Feb 2008 | B2 |
7341588 | Swanson | Mar 2008 | B2 |
7344538 | Myerson et al. | Mar 2008 | B2 |
7410488 | Janna et al. | Aug 2008 | B2 |
7524326 | Dierks | Apr 2009 | B2 |
7527627 | Ferrante et al. | May 2009 | B2 |
7582107 | Trail et al. | Sep 2009 | B2 |
7588577 | Fencl et al. | Sep 2009 | B2 |
7601153 | Shinjo et al. | Oct 2009 | B2 |
7608097 | Kyle | Oct 2009 | B2 |
7632272 | Munro et al. | Dec 2009 | B2 |
7655009 | Grusin | Feb 2010 | B2 |
7666212 | Patnak | Feb 2010 | B2 |
7670340 | Brivio et al. | Mar 2010 | B2 |
7713271 | Warburton | May 2010 | B2 |
7717947 | Wilberg et al. | May 2010 | B1 |
7731721 | Rathbun et al. | Jun 2010 | B2 |
7731738 | Jackson et al. | Jun 2010 | B2 |
7763022 | Speitling et al. | Jul 2010 | B2 |
7763023 | Gotfried | Jul 2010 | B2 |
7785326 | Green et al. | Aug 2010 | B2 |
7794483 | Capanni | Sep 2010 | B2 |
7799061 | Kay et al. | Sep 2010 | B2 |
7815646 | Hart | Oct 2010 | B2 |
7842036 | Phillips | Nov 2010 | B2 |
7867231 | Cole | Jan 2011 | B2 |
7892234 | Schlienger et al. | Feb 2011 | B2 |
7892264 | Sanders et al. | Feb 2011 | B2 |
7909825 | Saravia et al. | Mar 2011 | B2 |
7914532 | Shaver et al. | Mar 2011 | B2 |
7918853 | Watanabe et al. | Apr 2011 | B2 |
7922748 | Hoffman | Apr 2011 | B2 |
7927340 | Hart | Apr 2011 | B2 |
7938848 | Sweeney | May 2011 | B2 |
7947043 | Mutchler | May 2011 | B2 |
8034056 | Fencl et al. | Oct 2011 | B2 |
8034082 | Lee et al. | Oct 2011 | B2 |
8057476 | Ekholm et al. | Nov 2011 | B2 |
8092453 | Warburton | Jan 2012 | B2 |
8100910 | Warburton | Jan 2012 | B2 |
8100946 | Strausbaugh et al. | Jan 2012 | B2 |
8206424 | Biedermann et al. | Jun 2012 | B2 |
8353910 | Dell-Oca | Jan 2013 | B2 |
9289970 | Seo et al. | Mar 2016 | B2 |
20010021852 | Chappius | Sep 2001 | A1 |
20020032445 | Fujiwara | Mar 2002 | A1 |
20020052605 | Grooms et al. | May 2002 | A1 |
20020128712 | Michelson | Sep 2002 | A1 |
20020143333 | von Hoffmann et al. | Oct 2002 | A1 |
20020169453 | Berger | Nov 2002 | A1 |
20020197134 | Huber | Dec 2002 | A1 |
20030060827 | Coughlin | Mar 2003 | A1 |
20030065391 | Re et al. | Apr 2003 | A1 |
20030083667 | Ralph et al. | May 2003 | A1 |
20030147716 | Nagawa | Aug 2003 | A1 |
20030158555 | Sanders | Aug 2003 | A1 |
20030208270 | Michelson | Nov 2003 | A9 |
20030229346 | Oribe et al. | Dec 2003 | A1 |
20040006345 | Vlahos et al. | Jan 2004 | A1 |
20040049192 | Shimizu | Mar 2004 | A1 |
20040097945 | Wolf | May 2004 | A1 |
20040172031 | Rubecamp et al. | Sep 2004 | A1 |
20040181234 | McDevitt et al. | Sep 2004 | A1 |
20040193162 | Bramlet | Sep 2004 | A1 |
20040220570 | Frigg | Nov 2004 | A1 |
20050015092 | Rathbun et al. | Jan 2005 | A1 |
20050069397 | Shavit et al. | Mar 2005 | A1 |
20050107791 | Manderson | May 2005 | A1 |
20050125070 | Reiley | Jun 2005 | A1 |
20050149030 | Serhan et al. | Jul 2005 | A1 |
20050171544 | Falkner, Jr. | Aug 2005 | A1 |
20050171546 | Wolf | Aug 2005 | A1 |
20050192580 | Dalton | Sep 2005 | A1 |
20050240190 | Gall | Oct 2005 | A1 |
20050251147 | Novak | Nov 2005 | A1 |
20050273101 | Schumacher | Dec 2005 | A1 |
20050277940 | Neff | Dec 2005 | A1 |
20050283159 | Amara | Dec 2005 | A1 |
20060009774 | Goble et al. | Jan 2006 | A1 |
20060009846 | Trieu et al. | Jan 2006 | A1 |
20060015101 | Warburton et al. | Jan 2006 | A1 |
20060015123 | Fencl et al. | Jan 2006 | A1 |
20060052787 | Re et al. | Mar 2006 | A1 |
20060095039 | Mutchler | May 2006 | A1 |
20060122600 | Cole | Jun 2006 | A1 |
20060122612 | Justin et al. | Jun 2006 | A1 |
20060142770 | Capanni | Jun 2006 | A1 |
20060149243 | Vaughan | Jul 2006 | A1 |
20060149244 | Amrein et al. | Jul 2006 | A1 |
20060149257 | Orbay | Jul 2006 | A1 |
20060173461 | Kay et al. | Aug 2006 | A1 |
20060189991 | Bickley | Aug 2006 | A1 |
20060200141 | Janna | Sep 2006 | A1 |
20060200143 | Warburton | Sep 2006 | A1 |
20060200144 | Warburton | Sep 2006 | A1 |
20060200160 | Border et al. | Sep 2006 | A1 |
20060235396 | Sanders et al. | Oct 2006 | A1 |
20060241608 | Myerson et al. | Oct 2006 | A1 |
20060241777 | Partin et al. | Oct 2006 | A1 |
20060264954 | Sweeney, II et al. | Nov 2006 | A1 |
20070021839 | Lowe | Jan 2007 | A1 |
20070038306 | O'Gara | Feb 2007 | A1 |
20070055286 | Ralph et al. | Mar 2007 | A1 |
20070066977 | Assell et al. | Mar 2007 | A1 |
20070073290 | Boehm, Jr. | Mar 2007 | A1 |
20070093841 | Hoogland | Apr 2007 | A1 |
20070112432 | Reiley | May 2007 | A1 |
20070162028 | Jackson | Jul 2007 | A1 |
20070173835 | Medoff | Jul 2007 | A1 |
20070233114 | Bouman | Oct 2007 | A1 |
20070270848 | Lin | Nov 2007 | A1 |
20070270855 | Partin | Nov 2007 | A1 |
20080065224 | Reigstad et al. | Mar 2008 | A1 |
20080091203 | Warburton et al. | Apr 2008 | A1 |
20080132960 | Weaver et al. | Jun 2008 | A1 |
20080154271 | Berberich et al. | Jun 2008 | A1 |
20080208261 | Medoff | Aug 2008 | A1 |
20080221623 | Gooch | Sep 2008 | A1 |
20080269908 | Warburton | Oct 2008 | A1 |
20080279654 | Deschamps | Nov 2008 | A1 |
20080294164 | Frank et al. | Nov 2008 | A1 |
20080306487 | Hart | Dec 2008 | A1 |
20080306537 | Culbert | Dec 2008 | A1 |
20090018542 | Saravia et al. | Jan 2009 | A1 |
20090048600 | Matityahu et al. | Feb 2009 | A1 |
20090088804 | Kyle et al. | Apr 2009 | A1 |
20090088806 | Leyden et al. | Apr 2009 | A1 |
20090093813 | Elghazaly | Apr 2009 | A1 |
20090093849 | Grabowski | Apr 2009 | A1 |
20090093851 | Osman | Apr 2009 | A1 |
20090099571 | Cresina et al. | Apr 2009 | A1 |
20090118772 | Diederich | May 2009 | A1 |
20090149857 | Culbert | Jun 2009 | A1 |
20090157077 | Larsen et al. | Jun 2009 | A1 |
20090157078 | Mikol | Jun 2009 | A1 |
20090157079 | Warburton et al. | Jun 2009 | A1 |
20090157080 | Warburton | Jun 2009 | A1 |
20090177203 | Reiley | Jul 2009 | A1 |
20090198289 | Manderson | Aug 2009 | A1 |
20090209961 | Ferrante et al. | Aug 2009 | A1 |
20090240252 | Chang | Sep 2009 | A1 |
20090248025 | Haidukewych et al. | Oct 2009 | A1 |
20090264885 | Grant et al. | Oct 2009 | A1 |
20090281580 | Emannuel | Nov 2009 | A1 |
20090292292 | Fencl et al. | Nov 2009 | A1 |
20090306666 | Czartoski et al. | Dec 2009 | A1 |
20090326534 | Yamazaki et al. | Dec 2009 | A1 |
20100023011 | Nakamura | Jan 2010 | A1 |
20100023064 | Brunger et al. | Jan 2010 | A1 |
20100030280 | Jackson | Feb 2010 | A1 |
20100042164 | Lee et al. | Feb 2010 | A1 |
20100042167 | Nebosky et al. | Feb 2010 | A1 |
20100057141 | Abdelgany et al. | Mar 2010 | A1 |
20100069970 | Lewis et al. | Mar 2010 | A1 |
20100076499 | McNamara et al. | Mar 2010 | A1 |
20100121324 | Tyber | May 2010 | A1 |
20100121325 | Tyber et al. | May 2010 | A1 |
20100145397 | Overes | Jun 2010 | A1 |
20100174284 | Schwammberger et al. | Jul 2010 | A1 |
20100179551 | Keller et al. | Jul 2010 | A1 |
20100234846 | Eglseder | Sep 2010 | A1 |
20100256639 | Tyber et al. | Oct 2010 | A1 |
20100274296 | Appenzeller | Oct 2010 | A1 |
20100298889 | Wilberg | Nov 2010 | A1 |
20100312279 | Gephart et al. | Dec 2010 | A1 |
20110004255 | Weiner et al. | Jan 2011 | A1 |
20110022066 | Sevrain | Jan 2011 | A1 |
20110046681 | Prandi et al. | Feb 2011 | A1 |
20110060337 | Ferrante et al. | Mar 2011 | A1 |
20110106172 | Wallenstein | May 2011 | A1 |
20110137313 | Jensen et al. | Jun 2011 | A1 |
20110144645 | Saravia et al. | Jun 2011 | A1 |
20110160729 | Overes et al. | Jun 2011 | A1 |
20110218580 | Schwager et al. | Sep 2011 | A1 |
20110218585 | Krinke | Sep 2011 | A1 |
20110282398 | Overes et al. | Nov 2011 | A1 |
20110301651 | Kirschman | Dec 2011 | A1 |
20120004690 | Gonzalez-Hernandez | Jan 2012 | A1 |
20120010669 | O'Neil et al. | Jan 2012 | A1 |
20120016424 | Kave | Jan 2012 | A1 |
20120022603 | Kirschman | Jan 2012 | A1 |
20120095516 | Dikeman | Apr 2012 | A1 |
20120109213 | Appenzeller et al. | May 2012 | A1 |
Number | Date | Country |
---|---|---|
2738745 | Nov 2005 | CN |
21512134 | Feb 2010 | EP |
2861576 | May 2005 | FR |
199722301 | Jun 1997 | WO |
2006116164 | Nov 2006 | WO |
2007131287 | Nov 2007 | WO |
2008024373 | Feb 2008 | WO |
200906783 | Jun 2009 | WO |
2009120852 | Oct 2009 | WO |
Entry |
---|
Examination Report dated Dec. 12, 2018 for Indian Patent Application 355/MUMNP/2012. |
Number | Date | Country | |
---|---|---|---|
20210267648 A1 | Sep 2021 | US |
Number | Date | Country | |
---|---|---|---|
61132932 | Jun 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12658680 | Feb 2010 | US |
Child | 14599671 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17002005 | Aug 2020 | US |
Child | 17323923 | US | |
Parent | 15884048 | Jan 2018 | US |
Child | 17002005 | US | |
Parent | 15181435 | Jun 2016 | US |
Child | 15884048 | US | |
Parent | 14599671 | Jan 2015 | US |
Child | 15181435 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12456808 | Jun 2009 | US |
Child | 12658680 | US |